Announcements

Profound Medical Corp. filed a Form 8-K with the SEC on August 17, 2026, disclosing the introduction of the company's new real-time interventional MRI Software via a press release issued the same day.

TMC the Metals Company Inc. filed a Form 8-K with the SEC on August 17, 2026, disclosing that the National Oceanic and Atmospheric Administration has published a Notice of Intent to prepare an Environmental Impact Statement for a deep seabed exploration license application submitted …

NVIDIA Corporation filed a Form 8-K with the SEC on August 17, 2026, disclosing a multi-year partnership with SB Energy Corp. and the execution of residual value guaranties capped at $105 billion related to a large-scale AI data center campus in Pike County, Ohio.

Corebridge Financial, Inc. filed a Form 8-K on August 17, 2026 to submit audited and unaudited financial statements of Equitable Holdings, Inc. and unaudited pro forma combined financial statements of New Equitable in connection with a planned merger announced on March 26, 2026.

BridgeBio Pharma, Inc. filed a Form 8-K on August 17, 2026, disclosing that selling stockholder KKR Genetic Disorder L.P. entered into an Underwriting Agreement on August 13, 2026, to offer 5,000,000 shares of BridgeBio common stock at $78.00 per share.

Evolution Metals & Technologies Corp. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing condensed consolidated financial statements and management discussion as of August 17, 2026.

Padmanabh P. Bhatt, Senior Vice President of IP and Chief Scientific Officer of Supernus Pharmaceuticals, Inc., filed a Form 4 on August 14, 2026, disclosing transactions in common stock on August 12, 2026, related to the vesting of Performance Share Units.